Keywords
rheumatoid arthritis, psoriatic arthritis, pain management, curcumin, cannabinoid
Data Source
Rheumatology Clinic affiliated with a University
Abstract
Introduction
Rheumatoid (RA) and psoriatic arthritis (PsA) are autoimmune conditions that progressively destroy joints, causing chronic, often debilitating pain and drastically affecting the quality of life. Though cannabis has been legalized for medical use in most states in the United States (US), the safety and efficacy of its use in inflammatory arthritis have still not been satisfactorily established. It is also suggested that curcumin possesses potent anti-inflammatory properties.
Methods
This study utilized an observational, cross-sectional design to survey patients with RA and PsA presenting to a rheumatology clinic to establish the prevalence and perceived efficacy of curcumin and cannabinoids in an arthritic patient population.
Results
Data was collected from 290 patients, 71% RA and 40% PsA patients admitted to the current cannabinoid usage. There were self-reported pain, fatigue, and swelling improvements with both curcumin and cannabinoid compounds.
Discussion
This study found that a notable portion of this inflammatory arthritis population reported a history of use or ongoing cannabinoid and curcumin usage. Patients also had self-reported perceptions of symptom relief, possibly attributable to the placebo effect.
Release Date
2023
Document Type
Data
Language
English
College
medicine
Recommended Citation
Bhanusali, Neha and Purohit, Richa, "Prevalence and Perceived Efficacy in the treatment of Rheumatoid and Psoriatic Arthritis with Curcumin and Cannabinoids" (2023). Research Data and Datasets. 8.
https://stars.library.ucf.edu/datasets/8